Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
10.1073/pnas.1806655115 92 DengJ.YangM.ChenY.ChenX.LiuJ.SunS.et al
Retatrutide results from clinical trials show approximately 24.2% weight loss at 48 weeks, compared to roughly 16% with semaglutide (Ozempic/Wegovy) and 22.5% with tirzepatide (Mounjaro/Zepbound) at their respective maximum doses
As a result, this could lead to earlier glycemic control and better overall outcomes
A pivotal follow-up showing that the motor and cognitive benefits of exenatide persist long after discontinuation
US$ 28.78
US$ 21.79
US$ 21.05
US$ 25.35
US$ 22.52
US$ 23.92
US$ 28.89
